[1]蔡林秀,解强,张曦,等.抗骨质疏松药物不同给药途径研究进展[J].中华老年骨科与康复电子杂志,2022,(01):60-64.[doi:10.3877/cma.j.issn.2096-0263.2022.01.009]
 Cai Linxiu,Xie Qiang,Zhang Xi,et al.Development of the drug delivery approaches for osteoporosisd[J].Chin J Geriatr Orthop Rehabil(Electronic Edition),2022,(01):60-64.[doi:10.3877/cma.j.issn.2096-0263.2022.01.009]
点击复制

抗骨质疏松药物不同给药途径研究进展()
分享到:

中华老年骨科与康复电子杂志[ISSN:1674-3911/CN:11-9292/R]

卷:
期数:
2022年01期
页码:
60-64
栏目:
综述
出版日期:
2022-02-05

文章信息/Info

Title:
Development of the drug delivery approaches for osteoporosisd
作者:
蔡林秀1解强1张曦2高俊23孔泳4
213003 南京中医药大学附属常州市中医医院1;213003 常州市中医医院骨科2,骨靶向释药系统实验室3;213164 常州大学石油化工学院4
Author(s):
Cai Linxiu1 Xie Qiang1 Zhang Xi2 Gao Jun2 3 Kong Yong4
1Changzhou Chinese Traditional Medicine Hospital Affiliated to Chinese Traditional Medicine University of Nanjing, Changzhou 213003, China; 2Department of Orthopedics, Changzhou Hospital of Chinese medicine, Changzhou 213003, China; 3Bone- targeting drug delivery system laboratory, Changzhou Hospital of Chinese medicine, Changzhou 213003, China; 4School of Petrochemical Engineering, Changzhou University, Changzhou 213164, China
关键词:
骨质疏松症 给药途径 药物递送 受控释放 骨靶向
Keywords:
Osteoporosis Routes of administration Drug delivery Controlled release Bone-targeting
DOI:
10.3877/cma.j.issn.2096-0263.2022.01.009
文献标志码:
A
摘要:
随着老龄化社会的来临,骨质疏松症已经成为了世界范围内的主要健康问题之一。目前,临床上抗骨质疏松药物诸如双膦酸盐类、激素类、以及较新的骨细胞活性调节剂等,主要通过口服、静脉或皮下给药,这些传统方法都存在患者依从性差或生物利用度低的缺陷。为了更高效的治疗骨质疏松症及防范相关骨折风险,研究者们近年来在抗骨质疏松症的给药途径领域取得许多突破,利用纳米载体、骨靶向性基团修饰药物、被动和主动触发的储库系统都可以通过控制药物释放的速率、时间和作用部位提高治疗剂疗效、安全性及患者依从性。本文就抗骨质疏松症治疗的给药途径及新兴给药方法进行综述。
Abstract:
Osteoporosis have become the major public health problems worldwide in our aging society. Currently, Most of the clinically used antiresorptive and anabolic agents such bisphosphonates, asestrogen, along with newer modulators and antibodies, are primarily administered orally, intravenously, or subcutaneously. Traditional methods have defects of poor patient compliance or low bioavailability. In recent years, breakthroughs in the field of drug delivery have been made to treat osteoporosis and associated fracture risk more efficiently. The use of nano carriers, bone targeted group modified drugs, passively and active actively triggered release system can improve the efficacy and safety of therapeutic agents by controlling the rate, time andplace of drug release. This paper reviews routes of administration for treatment of osteoporosis with emphasis on emerging drug delivery routes.

相似文献/References:

[1]马晓龙,刘强,吴斗,等.骨质疏松显微骨折早期发生发展过程的实验研究[J].中华老年骨科与康复电子杂志,2016,(03):129.[doi:10.3877/cma.j.issn.2096-0263.2016.03.001]
 Ma Xiaolong,Liu Qiang,Wu Dou,et al.Experimental study of osteoporotic microsurgery fractures in the early development process[J].Chin J Geriatr Orthop Rehabil(Electronic Edition),2016,(01):129.[doi:10.3877/cma.j.issn.2096-0263.2016.03.001]
[2]崔红旺,蒋电明.骨细胞程序性死亡在骨质疏松中作用的研究进展[J].中华老年骨科与康复电子杂志,2016,(03):181.[doi:10.3877/cma.j.issn.2096-0263.2016.03.011]
 Cui Hongwang,Jiang Dianming.Effect of the programmed cell death of osteocyte on osteoporosis[J].Chin J Geriatr Orthop Rehabil(Electronic Edition),2016,(01):181.[doi:10.3877/cma.j.issn.2096-0263.2016.03.011]
[3]李子怡,李玉坤.OPG/RANK/RANKL信号通路在骨质疏松症中的研究进展和应用[J].中华老年骨科与康复电子杂志,2017,(02):124.[doi:10.3877/cma.j.issn.2096-0263.2017.02.012]
 Li Ziyi,Li Yukun.Researching progress and application of OPG-RANK-RANKL signaling pathway in osteoporosis[J].Chin J Geriatr Orthop Rehabil(Electronic Edition),2017,(01):124.[doi:10.3877/cma.j.issn.2096-0263.2017.02.012]
[4]雷涛,申勇.老年骨质疏松性椎体骨折若干问题的探讨[J].中华老年骨科与康复电子杂志,2017,(04):248.[doi:10.3877/cma.j.issn.2096-0263.2017.04.010]
 Lei Tao,Shen Yong..A brief discussion of osteoporotic vertebral fractures in elderly patients[J].Chin J Geriatr Orthop Rehabil(Electronic Edition),2017,(01):248.[doi:10.3877/cma.j.issn.2096-0263.2017.04.010]
[5]马树伟.球囊扩张椎体成形术治疗急性与亚急性期骨质疏松椎体压缩骨折的疗效对比[J].中华老年骨科与康复电子杂志,2017,(06):341.[doi:10.3877/cma.j.issn.2096-0263.2017.06.005]
 Ma Shuwei.Clinical efficacy of percutaneous kyphoplasty in the treatment of acute and subacute phase of osteoporotic vertebral compression fractures[J].Chin J Geriatr Orthop Rehabil(Electronic Edition),2017,(01):341.[doi:10.3877/cma.j.issn.2096-0263.2017.06.005]
[6]刘伟,傅光涛,胡旭民,等.唑来膦酸治疗绝经后骨质疏松发生脆性骨折的临床研究[J].中华老年骨科与康复电子杂志,2017,(06):351.[doi:10.3877/cma.j.issn.2096-0263.2017.06.007]
 Liu Wei,Fu Guangtao,Hu Xumin,et al.Analysis in postmenopausal osteoporosis patients with fragility fracture during zoledronic acid treatment[J].Chin J Geriatr Orthop Rehabil(Electronic Edition),2017,(01):351.[doi:10.3877/cma.j.issn.2096-0263.2017.06.007]
[7]邢浩,刘强,吴斗,等.双膦酸盐治疗股骨非典型性骨折的研究进展[J].中华老年骨科与康复电子杂志,2018,(02):118.[doi:10.3877/cma.j.issn.2096-0263.2018.02.010]
 Bisphosphonates and atypical femur fractures femur[J].Chin J Geriatr Orthop Rehabil(Electronic Edition),2018,(01):118.[doi:10.3877/cma.j.issn.2096-0263.2018.02.010]
[8]梁伟,吴斗,赵恩哲,等.皮质厚度在骨质疏松性髋部骨折中的应用研究[J].中华老年骨科与康复电子杂志,2018,(03):184.[doi:10.3877/cma.j.issn.2096-0263.2018.03.012]
 Liang Wei,Wu Dou,Zhao Enzhe,et al.Application research of Cortical thickness in osteoporotic hip fractures[J].Chin J Geriatr Orthop Rehabil(Electronic Edition),2018,(01):184.[doi:10.3877/cma.j.issn.2096-0263.2018.03.012]
[9]谢亚明,谢国盛,林蒙,等.网袋成形术与椎体后凸成形术治疗骨质疏松性椎体压缩骨折的早期疗效比较[J].中华老年骨科与康复电子杂志,2018,(04):202.[doi:10.3877/cma.j.issn.2096-0263.2018.04.003]
 Xie Yaming,Xie Guosheng,Lin Meng,et al.Early clinical outcome of vesselplasty and kyphoplasty in treatment of osteoporotic vertebral compression fractures[J].Chin J Geriatr Orthop Rehabil(Electronic Edition),2018,(01):202.[doi:10.3877/cma.j.issn.2096-0263.2018.04.003]
[10]吴石磊 刘勇 邵增务 田青. 骨组织细胞外泌体对骨代谢作用的研究现状[J].中华老年骨科与康复电子杂志,2018,(05):308.
 Wu Shilei,Liu Yong,Shao Zengwu,et al. Research status of bone tissue-derived exosomes on bone metabolism[J].Chin J Geriatr Orthop Rehabil(Electronic Edition),2018,(01):308.

备注/Memo

备注/Memo:
基金项目:江苏省社会发展重点研发项目(BE2019653);常州市卫生健康委科技项目资助(QN201721)
更新日期/Last Update: 2022-04-25